CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-09-07. AI was used for research and drafting; the existence of all 2 cited sources was verified (1 access-limited, verified via index/summary and marked), followed by blind grading, adversarial audit, and build validation. Methodology v0.8.
Verdict No. 3000 · Search date 2026-09-07 · Methodology v0.8

Supervised isometric wall-squat or wall-sit training three times weekly,
does it really help with Lower resting systolic blood pressure in untreated adults with hypertension?

30-Second Summary
C
Evidence Grade C · 54 · Safety caution
A short supervised resting-SBP signal, not evidence of medication replacement or cardiovascular-event prevention
The key 77-person trial reported no adverse events, but a separate acute study recorded mean pressure of 196/112 mmHg during a 90-degree hold. Long-term resting reduction and the acute in-exercise response are different time points.
What the
research shows
Grade C with 54 points. In a 77-person RCT, resting systolic pressure changed from 141.2 to 128.3 mmHg after 12 weeks of wall sits, versus 138.9 to 138.5 mmHg with no exercise. The diastolic between-group result was null and events or medication replacement were not tested.
What the
ads claim
Claims that once weekly is an effective starting dose, that wall sits equal medication, or that they prevent heart attacks were not directly tested.
*

Useful facts when choosing a product

  • The key prescription was four two-minute holds separated by two-minute seated rests.
  • Initial training was three times weekly for 12 weeks; once weekly was a later maintenance phase.
  • Knee angle, intensity calibration, and supervision are part of the intervention.
Gap Measurement · Verdict 3000 · C 54
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Seventy-seven untreated adults aged 35-65 with hypertension were assigned to handgrip, wall sit, or no exercise. Wall sits used four two-minute holds with two-minute seated rests, three times weekly for 12 weeks, followed by once-weekly maintenance.

02

Why this is classified as C (54)

Public funding and a large controlled SBP signal are strengths, but resting pressure is a surrogate and the key trial had 77 participants, giving grade C with 54 points.

Counterpoint. All 77 completed and no adverse events were reported, but this was a limited supervised sample.

Rejudgment record. Codex cross-check of key and sham RCTs, funding, and acute safety evidence — Separated Cohen SBP from DBP, initial training from maintenance, and lower resting pressure from elevated pressure during a hold

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE+Meets the clinically important threshold
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Lower resting SBP after 12 weeks of supervised wall sitsCThe key trial had a -12.9-mmHg within-group change.
Improved diastolic blood pressureDThe key trial's between-group result was null.
Medication replacement or cardiovascular-event prevention?Events and treatment replacement were not tested.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Multicenter three-arm randomized trial77Colombian Ministry of Science/Colciencias; no conflicts declaredTwelve-week office resting pressure and maintenanceSBP 141.2 to 128.3 vs 138.9 to 138.5 mmHg; DBP between-group nullKey hypertension RCT
Study 2Randomized wall-sit, low-intensity sham, and no-exercise trial30Funding information not providedFour-week resting SBP and DBPSBP -15.2±9.2 and DBP -4.6±5.0 mmHg; P<.05 vs controlsSmall supportive trial
§

Receipt — 2 References

Of 2 cited sources, 1 had limited original-page access (blocked or summary-only) and were verified via index/summary, marked partial; the rest were verified at the original page. As of 2026-09-07.

Cohen DD, Aroca-Martinez G, Carreño-Robayo J, et al. Reductions in systolic blood pressure achieved by hypertensives with three isometric training sessions per week are maintained with a single session per week. J Clin Hypertens. 2023;25(4):380-387. PMID: 36965163. PMCID: PMC10085809. DOI: 10.1111/jch.14621.
partial
Decaux A et al. Blood pressure and cardiac autonomic adaptations to isometric exercise training: A randomized sham-controlled study. Physiol Rep. 2022;10(2):e15112. PMID: 35083878. PMCID: PMC8792514. DOI: 10.14814/phy2.15112. NCT05025202.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none

Cite this verdict

Wall-Sit Training for Resting Systolic Pressure—Diastolic Benefit Remains Unconfirmed Evidence Grade C card
[Chamgap] Wall-Sit Training for Resting Systolic Pressure—Diastolic Benefit Remains Unconfirmed — Evidence Grade C·54. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/isometric-wall-sit-training-resting-systolic-blood-pressure/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.